Article Text

Download PDFPDF
Sporadic inclusion body myositis: evidence of a link between inflammation, cell stress and β-amyloid deposition
  1. Frank Mastaglia
  1. Correspondence to Professor Frank Mastaglia, Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Queen Elizabeth II Medical Centre, Nedlands, WA 6009, Australia; flmast{at}cyllene.uwa.edu.au

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Sporadic inclusion body myositis (sIBM) is the most important muscle disease associated with aging which is usually unresponsive to treatment and results in progressive disability with a selective pattern of muscle wasting and weakness of the quadriceps and forearm muscles.1 2 There has been longstanding debate as to whether sIBM is a primary inflammatory myopathy or a myodegenerative disorder with secondary inflammation. The relationship between the T cell predominant inflammatory response which tends to predominate in the earlier stages of the disease and the myofibre degeneration and amyloid deposits which become more prominent as the disease progresses …

View Full Text

Footnotes

  • Competing interests None.

  • Provenance and Peer review Commissioned; not externally peer reviewed.

Linked Articles